These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4050061)

  • 21. [Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
    Costanza G; Di Salvo A; Barone G; Verruso G; Zamueli M; Marchese G
    Minerva Cardioangiol; 1999 Dec; 47(12):649-50. PubMed ID: 10670244
    [No Abstract]   [Full Text] [Related]  

  • 22. PGE(1) short term therapy in critical lower limb ischemia.
    Bandiera G; Forletta M; Di Paola FM; Cirielli C
    Int Angiol; 2003 Mar; 22(1):58-63. PubMed ID: 12771858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolic effects of intermittent exercise by patients with stage II arterial occlusive disease].
    Maass U; Goller B; Grote R
    Vasa; 1995; 24(2):141-7. PubMed ID: 7793146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement of muscle oxygen pressure in healthy subjects and patients with arterial occlusive disease].
    Creutzig A
    Fortschr Med; 1985 Jul; 103(26):694-6. PubMed ID: 4043899
    [No Abstract]   [Full Text] [Related]  

  • 26. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
    Horch R; Krönung G
    Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
    [No Abstract]   [Full Text] [Related]  

  • 27. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
    Fagrell B; Lundberg G; Olsson A; Ostergren J
    Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemodynamic effects of intravenous PGE1 on patients with arterial occlusive disease of the leg.
    Hirai M; Nanki M; Nakayama R
    Angiology; 1985 Jul; 36(7):407-13. PubMed ID: 4040721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

  • 30. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
    Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
    Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraarterial perfusion of prostaglandin E1 after lumbar sympathectomy or reconstruction on femoropopliteal segment.
    Davidovic LB; Vranes MR; Lotina SI; Cernak IF; Velimirovic DB; Stojanov PL; Sindjelic RP; Sagic DZ; Cinara IS
    Int Angiol; 1991; 10(3):178-81. PubMed ID: 1765722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood circulation studies and analysis of acid metabolites during and after ergometric loading of the lower extremities in healthy subjects and in patients with chronic stage II arterial occlusion of the extremities].
    Brock FE; Rudofsky G; Ullrich M; Heimsch E; Gutmann J; Nobbe F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1745-9. PubMed ID: 611924
    [No Abstract]   [Full Text] [Related]  

  • 34. [1st experiences with prostaglandin E1 long-term intra-arterial perfusion in advanced arterial occlusive disease of the lower extremities stage IV].
    Gruss JD; Kawai S; Karadedos C; Bartels D
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1624-5. PubMed ID: 699778
    [No Abstract]   [Full Text] [Related]  

  • 35. [Angiospasm and spamolytic therapy in arterial diseases of the extremities].
    Koshkin VM
    Khirurgiia (Mosk); 1979 Sep; (9):71-5. PubMed ID: 502311
    [No Abstract]   [Full Text] [Related]  

  • 36. [Fully implantable catheter systems for arterial extremity infusion].
    Krawzak HW; Strosche H
    Chirurg; 1989 Jul; 60(7):475-8. PubMed ID: 2791734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 38. Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive disease.
    Creutzig A; Caspary L; Alexander K
    Klin Wochenschr; 1990 Feb; 68(4):207-12. PubMed ID: 2314008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.